Gene · 53353
Papers2,235
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,235
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinicopathological features of SMARCA4-deficient non-small cell lung cancer. | Pathol Res Pract | 2025 | 41004982 | PubTator, text mining | PubMed |
| Multi-omics analysis of parthanatos related molecular subgroup and prognostic model development in stomach adenocarcinoma. | PLoS One | 2025 | 41004487 | PubTator, text mining | PubMed |
| IBI-DT: a novel approach combining individualized Bayesian inference and decision tree for identifying cancer drivers and their interactions. | Brief Bioinform | 2025 | 40975833 | PubTator, text mining | PubMed |
| Low expression of HSP27 and HSP70 predicts poor prognosis in laryngeal squamous cell carcinoma. | J Cancer Res Clin Oncol | 2025 | 40971071 | PubTator, text mining | PubMed |
| Circulating tumor DNA as a marker of molecular residual disease in resected esophageal squamous cell carcinoma. | Mol Biomed | 2025 | 40963072 | PubTator, text mining | PubMed |
| Spatial colocalization and molecular crosstalk of myofibroblastic CAFs and tumor cells shape lymph node metastasis in oral squamous cell carcinoma. | PLoS Genet | 2025 | 40906645 | PubTator, text mining | PubMed |
| Mutational landscape and tyrosine kinase inhibitor sensitivity in EGFR L833 and H835 mutated non-small cell lung cancer. | Cancer | 2025 | 40886084 | PubTator, text mining | PubMed |
| DNA methylation and transcription factor-driven immune subtypes in ovarian cancer. | Discov Oncol | 2025 | 40875153 | PubTator, text mining | PubMed |
| Mutational profile of oropharyngeal squamous cell carcinoma in relation to HPV, tobacco smoking and prognosis with validation in the DAHANCA 19 randomized trial. | Acta Oncol | 2025 | 40859705 | PubTator, text mining | PubMed |
| Modelling Acral Melanoma in Admixed Brazilians Uncovers Genomic Drivers and Targetable Pathways. | medRxiv | 2025 | 40832384 | PubTator, text mining | PubMed |
| Identification of neoantigen epitopes in cervical cancer by multi-omics analysis. | Eur J Med Res | 2025 | 40826144 | PubTator, text mining | PubMed |
| The genetic architecture of cervical length is shared with spontaneous preterm birth risk. | Commun Med (Lond) | 2025 | 40813921 | PubTator, text mining | PubMed |
| Mutational analysis of primary and advanced chordoma tissue using next-generation sequencing. | Cancer | 2025 | 40802536 | PubTator, text mining | PubMed |
| SDR42E1 modulates vitamin D absorption and cancer pathogenesis: insights from an in vitro model. | Front Endocrinol (Lausanne) | 2025 | 40756515 | PubTator, text mining | PubMed |
| Gene Expression Analysis of Papillary Thyroid Carcinoma With Lymph Node Metastasis and Radioiodine Refractivity. | Cureus | 2025 | 40746809 | PubTator, text mining | PubMed |
| Integrated system for screening tumor-specific TCRs, epitopes, and HLA subtypes using single-cell sequencing data. | J Immunother Cancer | 2025 | 40744664 | PubTator, text mining | PubMed |
| Clinical and Genetic Predictors of Sickle Cell Nephropathy: A Global Systematic Review. | OMICS | 2025 | 40719369 | PubTator, text mining | PubMed |
| Molecular Characterization of NUT Carcinoma: A Report from the NUT Carcinoma Registry. | Clin Cancer Res | 2025 | 40704901 | PubTator, text mining | PubMed |
| Genomic Signatures of Poor Prognosis in Merkel Cell Carcinoma: A Single-Institution Prospective Study. | Mol Cancer Res | 2025 | 40689859 | PubTator, text mining | PubMed |
| Narrative Review: Predictive Biomarkers of Tumor Response to Neoadjuvant Radiotherapy or Total Neoadjuvant Therapy of Locally Advanced Rectal Cancer Patients. | Cancers (Basel) | 2025 | 40647527 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/53353/papers?page=4